16.2 C
October 22, 2021

Antibiotice Iasi and Cantacuzino Institute might merge into national pharma company

PSD leader Mircea Geoana declared yesterday, at the opening of the BVB trading session that forming a national pharmaceutical company to include Antibiotice Iasi and the Cantacuzino Institute, with a stock exchange component, might draw additional financial resources. The PSD leader said Romania must not depend on the import of strategic medical drugs, when faced with risk of pandemics, and it should have its own capacity of pharmaceutical production as part of the national security system.

The PSD leader wants to further exempt from taxation, in 2010 too, the profit made from stock exchange transactions, as a stimulus for investments on the capital market. The decision not to tax capital market gains was applied early this year to help investors cope with the economic crisis. Geoana also said Tuesday, before the opening bell on the Bucharest Stock Exchange, that Romania should take advantage of the revenue resources of the Fondul Proprietatea investment fund and the trade of carbon dioxide emission certificates. “We have a few hundreds of million of euros from Fondul Proprietatea, and we could gain over EUR 1 billion from trading green certificates. These issues must be debated by the future prime minister and finance minister, to find a use for these funds,” he added.

Related posts

ASF: Pension funds should increase their direct investments

Nine O' Clock

Mazars report on the new digital world: Leadership lessons, cultural challenges, and how to harness AI for a better future


Gruia Dufaut Law Office presents: Soil quality certificate: Increased obligations of landowners